Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non-Small-Cell Lung Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 1, 2007, Pages 94-102

  Yom, Sue S ^a   Liao, Zhongxing ^a   Liu, H Helen ^a   Tucker, Susan L ^a   Hu, Chao Su ^b   Wei, Xiong ^a   Wang, Xuanming ^a   Wang, Shulian ^c   Mohan, Radhe ^a   Cox, James D ^a   Komaki, Ritsuko ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

3D CRT; Chemoradiation; IMRT; Non small cell lung cancer; Treatment related pneumonitis

Indexed keywords

CHEMOTHERAPY; DOSIMETRY; RADIATION EFFECTS; RADIOTHERAPY; SURGERY; TUMORS;

CHEMORADIATION; NON-SMALL-CELL LUNG CANCERS; TREATMENT-RELATED PNEUMONITIS;

PULMONARY DISEASES;

AMIFOSTINE; CARBOPLATIN; CELECOXIB; CISPLATIN; ETOPOSIDE; GEMCITABINE; IRINOTECAN; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS; COMPUTER ASSISTED RADIOTHERAPY; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RATING SCALE; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; TUMOR VOLUME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 34247164024     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.031     Document Type: Article

References (43)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Choi Y.W., Munden R.F., Erasmus J.J., et al. Effects of radiation therapy on the lung: Radiologic appearances and differential diagnosis. Radiographics 24 (2004) 985-997 discussion 998
3. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
4. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54 (2002) 329-339
5. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
6. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 67 (2003) 275-283
7. Claude L., Perol D., Ginestet C., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: Clinical and dosimetric factors analysis. Radiother Oncol 71 (2004) 175-181
8. Kim T.H., Cho K.H., Pyo H.R., et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 235 (2005) 208-215
9. Robnett T.J., Machtay M., Vines E.F., et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 89-94
10. Johansson S., Bjermer L., Franzen L., et al. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol 49 (1998) 41-47
11. Yamada M., Kudoh S., Hirata K., et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 34 (1998) 71-75
12. Roach III M., Gandara D.R., Yuo H.S., et al. Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors. J Clin Oncol 13 (1995) 2606-2612
13. Fay M., Tan A., Fisher R., et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1355-1363
14. Wang S., Liao Z.X., Wei X., et al. Analysis of clinical and dosimetric factors associated with treatment related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy (CCT) and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66 (2006) 1399-1407
15. Mell L.K., Mehrotra A.K., and Mundt A.J. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer 104 (2005) 1296-1303
16. Hong T.S., Ritter M.A., Tome W.A., et al. Intensity-modulated radiation therapy: Emerging cancer treatment technology. Br J Cancer 92 (2005) 1819-1824
17. Choi Y., Kim J.K., Lee H.S., et al. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) 683-689
18. Beavis A.W., Abdel-Hamid A., and Upadhyay S. Re-treatment of a lung tumour using a simple intensity-modulated radiotherapy approach. Br J Radiol 78 (2005) 358-361
19. Wu V.W., Kwong D.L., and Sham J.S. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol 71 (2004) 201-206
20. Grills I.S., Yan D., Martinez A.A., et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 57 (2003) 875-890
21. Murshed H., Liu H.H., Liao Z., et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1258-1267
22. Liu H.H., Wang X., Dong L., et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1268-1279
23. Pan T., Lee T.Y., Rietzel E., et al. 4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT. Med Phys 31 (2004) 333-340
24. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48 (2000) 1015-1024
25. Kung J.H., Zygmanski P., Choi N., et al. A method of calculating a lung clinical target volume DVH for IMRT with intrafractional motion. Med Phys 30 (2003) 1103-1109
26. Liu H.H., Jauregui M., Zhang X., et al. Beam angle optimization and reduction for intensity-modulated radiation therapy of non-small-cell lung cancers. Int J Radiat Oncol Biol Phys 65 (2006) 561-572
27. Movsas B., Raffin T.A., Epstein A.H., et al. Pulmonary radiation injury. Chest 111 (1997) 1061-1076
28. Ling C.C., Yorke E., Amols H., et al. High-tech will improve radiotherapy of NSCLC: A hypothesis waiting to be validated. Int J Radiat Oncol Biol Phys 60 (2004) 3-7
29. Mehta M., Scrimger R., Mackie R., et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 49 (2001) 23-33
30. Yartsev S., Chen J., Yu E., et al. Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases. Radiother Oncol 78 (2006) 169-176
31. Schwarz M., Alber M., Lebesque J.V., et al. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 62 (2005) 561-570
32. Holloway C.L., Robinson D., Murray B., et al. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 73 (2004) 285-287
33. Gopal R., Tucker S.L., Komaki R., et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56 (2003) 106-113
34. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
35. Bortfeld T., Jokivarsi K., Goitein M., et al. Effects of intra-fraction motion on IMRT dose delivery: Statistical analysis and simulation. Phys Med Biol 47 (2002) 2203-2220
36. Chui C.S., Yorke E., and Hong L. The effects of intra-fraction organ motion on the delivery of intensity-modulated field with a multileaf collimator. Med Phys 30 (2003) 1736-1746
37. Jiang S.B., Pope C., Al Jarrah K.M., et al. An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments. Phys Med Biol 48 (2003) 1773-1784
38. Schaefer M., Munter M.W., Thilmann C., et al. Influence of intra-fractional breathing movement in step-and-shoot IMRT. Phys Med Biol 49 (2004) N175-N179
39. Jensen A.D., Munter M.W., Bischoff H., et al. Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: The NEAR protocol. (NCT00115518). BMC Cancer 6 (2006) 122
40. Liu H.H., Verhaegen F., and Dong L. A method of simulating dynamic multileaf collimators using Monte Carlo techniques for intensity-modulated radiation therapy. Phys Med Biol 46 (2001) 2283-2298
41. Jang S., Liu H.H., Wang X., et al. Dosimetry verification for intensity-modulated radiation therapy of thoracic cancers using experimental and Monte Carlo approaches. Int J Radiat Oncol Biol Phys 66 (2006) 939-948
42. Chang J.Y., Zhang X., Wang X., et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1087-1096
43. Chang J.Y., Liu H.H., and Komaki R. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer. Curr Oncol Rep 7 (2005) 255-259